It was reported the middle lumen of two catheters from triple lumen polyurethane central venous catheter sets were punctured and leaked.The first device was flushed with saline and placed in the patient.Upon infusion of medication, leakage was noted at the manifold/tubing connection of the center lumen.The device was removed.A second device was flushed and again a leak was noted in the same location, so the device was not placed in the patient.A new device was placed to complete the procedure.It was also noted that the device was secured to the patient via needle and suture.No adverse effects were reported.This event was previously reported under medwatch report numbers 1820334-2021-01441 and 1820334-2021-01442.However, upon further investigation, it was determined that this incident was independent of those previously reported.Thus, prompting the submission of this report.
|
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Investigation ¿ evaluation.It was reported by (b)(6) of (b)(6), argentina that on (b)(6) 2021 the middle lumen of two triple lumen polyurethane central venous catheters (rpn: c-utlm-501j-rsc; lot: ns8967346) were punctured and leaked.The first device was flushed with saline and placed in the patient.Upon infusion of medication, leakage was noted at the manifold/tubing connection of the center lumen.The device was removed.A second device was flushed and again a leak was noted in the same location, so the device was not placed in the patient.A new device was placed to complete the procedure.It was also noted that the device was secured to the patient via needle and suture.No adverse effects were reported.Reviews of documentation including the complaint history, device history record (dhr), quality control, and instructions for use (ifu) were conducted during the investigation.The complaint device was not returned for evaluation.However, a document-based investigation evaluation was performed.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.A review of the dhrs for the reported complaint device lot and related subassembly lots revealed no relevant non-conformances.A search of database records found two additional complaints involving the reported lot number which were received from the same facility, having the identical reported difficulty.However, since there is objective evidence the dhr was fully executed, cook medical has concluded there is no evidence that the devices were manufactured out of specification.Cook also reviewed product labeling.Instructions for use (ifu) document [c_t_ulmbhce_rev 6 [uncoated and heparin-coated central venous catheters] is packaged with this device.The product ifu states the following in consideration of the reported failure mode: suggested catheter maintenance: to prevent clotting or possibility or air embolus, the double lumen¿s #2 lumen, the triple-lumen¿s #2 and #3 lumens, and the five-lumens #2, #3, #4, and #5 lumens should be filled with saline solution or heparinized saline solution (100 units of heparin per ml of saline is usually adequate), depending on institutional protocol, prior to catheter introduction.Any unused lumens should be maintained with continuous saline or heparinized saline drip or locked with heparinized saline solution.Precautions if lumen flow is impeded, do not force injection or withdrawal of fluids.Failure to ensure patency of the catheter prior to power injection studies may result in catheter failure.Notify attending physician immediately.How supplied upon removal from package, inspect the product to ensure no damage has occurred.Based on the available information, no device return, and the results of the investigation, cook has concluded the root cause for this event is component failure, being defined as component failure without any design or manufacturing issue.The appropriate personnel have been notified.Cook will continue to monitor for similar complaints.Per the risk assessment no further action is required.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|